HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepsin inhibits CDK11p58 IRES activity by suppressing unr expression and eIF-2α phosphorylation in prostate cancer.

Abstract
Hepsin is a type II transmembrane serine protease frequently overexpressed in prostate cancer (PCa). However, the role of hepsin in PCa remains unclear. In this study, we found that hepsin inhibited the internal ribosome entry site (IRES) activity and expression of CDK11p58, which is associated with cell cycle progression and pro-apoptotic signaling in PCa. Hepsin suppressed CDK11p58 IRES activity in PCa by modulating unr expression and eIF-2α phosphorylation. Further studies revealed that hepsin inhibited the expression of unr by directly binding to unr IRES element and suppressing its activity, and also repressed eIF-2α phosphorylation through down-regulating the expression and phosphorylation of general control non-derepressible-2 (GCN2). Taken together, our data suggest a novel role of hepsin in regulating CDK11p58 IRES activity, and imply that hepsin may act on the machinery of translation to modulate cell cycle progression and survival in PCa cells.
AuthorsChunyi Zhang, Mingming Zhang, Qingyu Wu, Jianhao Peng, Yuanyuan Ruan, Jianxin Gu
JournalCellular signalling (Cell Signal) Vol. 27 Issue 4 Pg. 789-97 (Apr 2015) ISSN: 1873-3913 [Electronic] England
PMID25576733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Chemical References
  • CCND3 protein, human
  • CSDE1 protein, human
  • Cyclin D3
  • DNA-Binding Proteins
  • Eukaryotic Initiation Factor-2
  • Internal Ribosome Entry Sites
  • RNA-Binding Proteins
  • Serine Endopeptidases
  • hepsin
Topics
  • Cell Cycle
  • Cell Line, Tumor
  • Cyclin D3 (genetics)
  • DNA-Binding Proteins (genetics)
  • Eukaryotic Initiation Factor-2 (metabolism)
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Internal Ribosome Entry Sites
  • Male
  • Prostate (metabolism, pathology)
  • Prostatic Neoplasms (genetics, metabolism, pathology)
  • RNA-Binding Proteins (genetics)
  • Serine Endopeptidases (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: